资讯

Sand and Snow on MSN8 小时
NerveFreedom Review 2025: The Daily Supplement Users Are Calling a Game-Changer for ...
In This Article, You'll Discover Understanding how NerveFreedom's unique formulation addresses multiple aspects of ner ...
PipelineReview.com19 小时
Asahi Kasei Pharma Starts Phase III Study of Promising CIPN Prevention Therapy, ART-123 ...
CHELMSFORD, MA, USA & NOVI, MI, USA & DÜSSELDORF, Germany & TOKYO, Japan I July 02, 2025 I Asahi Kasei Pharma has started trial drug ...